[[link removed]] Weekly Digest
Weekly Digest
Letter from an Editor | March 30, 2024
Dear John,
On Tuesday, the Supreme Court heard arguments in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration— a case that seeks to overturn the FDA’s approval for the drug mifepristone, one of the two medications used to complete a self-managed abortion.
In the lead-up to the Court’s hearing of the case, a Texas district court initially ruled that the FDA had acted improperly in approving the medication, and that it should be removed from the market. The Department of Justice appealed the decision to the Fifth Circuit, which ruled that while the statute of limitations had passed for challenging the original approval, subsequent FDA regulations around Mifepristone should be rescinded. Again the DOJ appealed the decision; left to stand the ruling would prohibit telemedicine and mailing of the medication, reinstate the in-person visits requirement and prohibit non-physicians from prescribing—thus impacting abortion provision nationwide even in states without bans like California and New York.
In the oral arguments, a major issue that came up was that of standing: namely, whether the plaintiffs even have the right to bring the case. “In brief, the plaintiffs need to show that they have a ‘genuine stake’ in the case outcome,” wrote Ms. contributor and legal scholar Aziza Ahmed. “These plaintiffs—physicians who claim that they might have to treat women for self-induced abortion, but never have experienced any of the harms they assert they may be faced with—are asserting a link that is even too attenuated for the Supreme Court justices to find standing.”
But regardless of whether the Court chooses to overturn the lower courts’ rulings on the basis of standing, the fact remains that the case made it to the Supreme Court. It's clear that attacks on abortion like Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration are just going to keep coming. The far-right Heritage Foundation's "Project 2025" policy agenda—written by Trump allies and advisors—urges the next Republican president to order the FDA to withdraw Mifepristone from the market, and targets laws that protect telemedicine abortion providers.
In the face of these attacks, abortion rights supporters are pointing at what could be a powerful tool to counteract them, if enshrined in the Constitution: the federal Equal Rights Amendment. In Nevada, a district court recently ruled that the state’s Equal Rights Amendment safeguards Medicaid funding for abortions. And in Pennsylvania, the state Supreme Court found that abortion providers can challenge the state’s ban on Medicaid funding for abortions on the basis of sex discrimination, and that the ban is presumptively unconstitutional under Pennsylvania's state ERA.
This week, we launched a new project, in collaboration with the ERA Project at Columbia Law, the Birnbaum Women’s Leadership Center at NYU Law, and our publisher, Feminist Majority Foundation: “The ERA is Essential to Democracy.” This curated series answers key questions: What will it take to fully and finally recognize the ERA as the 28th Amendment? How strong is public support for the ERA? (Spoiler alert: VERY.) What are modern state-level ERAs already accomplishing? And how will the ERA help turn the tide against rollbacks to abortion and reproductive freedom in our post-Dobbs society?
I invite you to explore the website, which features essays, taped conversations, and a podcast episode, here [[link removed]] .
Onward,
[[link removed]]
Kathy Spillar
Executive Editor
This Week's Must-Reads from Ms.
[link removed] [[link removed]] [link removed] [[link removed]]
Supreme Court Abortion Pill Case Begs the Question: Will the Majority Let Reason Prevail? [[link removed]] The Abortion Pill and the Hypocritical Oath [[link removed]]
[link removed] [[link removed]] [link removed] [[link removed]]
Project 2025: Republicans’ Plan to Ban Abortion Pills Nationwide [[link removed]] State ERAs Can Protect Reproductive Rights Post-Dobbs [[link removed]]
[link removed] [[link removed]]
[link removed] [[link removed]] Tune in for a new episode of Ms. magazine's podcast, On the Issues with Michele Goodwin on
Apple Podcasts [[link removed]] + Spotify [[link removed]] .
The fight to enshrine gender equality in the U.S. Constitution is more urgent than ever. Nobody knows this better than Susan Frietsche—who recently secured an incredible victory for women in the state of Pennsylvania in terms of then power of the Equal Rights Amendment as it relates to reproductive freedom. In this episode, we delve into how Susan’s work sets an important precedent for protecting women’s rights—and how it relates to the fight to secure the federal ERA in the Constitution.
We hope you'll listen, subscribe, rate and review today!
[link removed] [[link removed]]
U.S. democracy is at a dangerous inflection point—from the demise of abortion rights, to a lack of pay equity and parental leave, to skyrocketing maternal mortality, and attacks on trans health. Left unchecked, these crises will lead to wider gaps in political participation and representation. For 50 years, Ms . has been forging feminist journalism—reporting, rebelling and truth-telling from the front-lines, championing the Equal Rights Amendment, and centering the stories of those most impacted. With all that’s at stake for equality, we are redoubling our commitment for the next 50 years. In turn, we need your help, Support Ms. today with a donation—any amount that is meaningful to you [[link removed]] . We are grateful for your loyalty and ferocity .
READ THE REST [[link removed]] | GET THE MAGAZINE [[link removed]] | SUPPORT MS. [[link removed]]
[[link removed]]
[link removed] [[link removed]] [link removed] [[link removed]] [link removed] [[link removed]]
Enjoy this newsletter? Forward to a friend!
Was this email forwarded to you by a friend? Subscribe [[link removed]] .

Ms. Magazine
1600 Wilson Boulevard
Suite 801
Arlington, VA 22209
United States
Manage your email subscriptions here [[link removed]]
If you believe you received this message in error or wish to no longer receive email from us, please
unsubscribe: [link removed] .